FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102023 [Registered on: 27/01/2026] Trial Registered Prospectively
Last Modified On: 23/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [karnavedhana therapy]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Two Ayurvedic Therapies Along with Herbal Medicine in the Treatment of Bronchial Asthma 
Scientific Title of Study   A comparative clinical study on effect of Vamana Karma and Karna Vedhana therapy along with Kulatthadi Kwatha in the management Of Tamaka Shwasa with special reference to Bronchial Asthma 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ankit Patel 
Designation  MD Scholar 
Affiliation  Faculty of Ayurveda Banaras hindu University varanasi 
Address  Department of kayachikitsa FOA IMS BHU Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  9713626496  
Fax    
Email  ankitgound092@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  profRajendra Prasad 
Designation  professor  
Affiliation  Faculty of Ayurveda Banaras hindu University varanasi 
Address  Department of kayachikitsa FOA IMS BHU Varanasi

Varanasi
UTTAR PRADESH
221005
India 
Phone  9411471910  
Fax    
Email  rajendraprasad051@gmail.com  
 
Details of Contact Person
Public Query
 
Name  profRajendra Prasad 
Designation  professor  
Affiliation  Faculty of Ayurveda Banaras hindu University varanasi 
Address  Department of kayachikitsa FOA IMS BHU Varanasi


UTTAR PRADESH
221005
India 
Phone  9411471910  
Fax    
Email  rajendraprasad051@gmail.com  
 
Source of Monetary or Material Support  
department of kayachikitsa BHU varanasi 221005 
department of medicinal chemistry BHU varanasi 221005 
DEPARTMENT OF PANCHKARMA BHU varanasi 221005 
 
Primary Sponsor  
Name  Banaras Hindu University 
Address  Lanka,BHU varanasi 221005 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
ANKIT PATEL  Sir sunderlal hospital  room no 22,department of kayachikitsa BHU VARANASI
Varanasi
UTTAR PRADESH 
9713626496

ankitgound092@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSITITUTIONAL ETHICS COMMITTEE OF BANARAS HINDU UNIVERSITY  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J453||Mild persistent asthma. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: kulatthadi kwatha, Reference: yogratnakar, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmProcedure-vedhana-karma, वेधन-कर्म (Procedure Reference: sushrut sutrasthan 16/3, Procedure details: Karna Vedhana procedure is done at the external ear(particularly at concha) by pointed silver needle 15 • Left ear generally preferred for the procedure as it is more convenient for right handed physician and vice versa •Patient is to be prepared mentally for the procedure by convincing him for karna Vedhana •Written consent form is to be signed by him/her before procedure.)
3Comparator ArmProcedure-vamanakarma, वमनकर्म (Procedure Reference: charaka siddhisthana, Procedure details: Snehana Svedana followed by Vamana Karma)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.
Patients willing to participate in the study.
2.
Patients of either sex with age between 18-60 years.
3.
Patients with history of Tamaka Shwasa less than 5 years.
4.
Patients presenting with classical features of Tamaka aShwasa.
5.
Peak flow meter rate more than 80 lit/min and less than 300 lit/min
6.
FVC (Forced Vital Capacity) and FEV1 (Forced Expiratory volume in one second) more than 60% and less than 80%.
7.
FEV1/FVC ratio more than 5% and less than 20%
 
 
ExclusionCriteria 
Details  1.Patients not willing to participate in the study.
2.
Patients of either sex below 18 years & above 60 years will be excluded from the study.
3.
Patient with history of Tamaka Shwasa more than 5 years.
17
4.
Pregnant and lactacting women.
5.
Emphysema
6.
Bronchial Carcinoma
7.
Pleural Effusion.
8.
Tuberculosis.
9.
Neurological disorders like epilepsy, heamorrhagic stroke, meningitis.
10.
Psychological disorders
11.
Status Asthmaticus
12.
Diabetes mellitus
13.
Hypertensive patient
14.
Occupational asthma, Cardiac Asthma.
15.
Emergency patients requiring O2 inhalation. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes/ Relief in subjective and objective parameter for Tamaka Shwasa.  4 weeks,8 weeks,12weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Depending upon subjective & objective parameter, assessment of response will be made based on Gradation Index mentioned before & after treatment.
Grading of assessment criteria of main symptoms described in Ayurvedic texts & modern texts.
Statistical analysis will be made using ‘t’ & ‘F’ test. 
3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   a total number patient will be taken for study is 60. it is divided in two groups each of 30 patients. Group A will be recieving vamana karma along with kullatthadi kwatha and group B will having karna vedhana with same kwatha in tamaka shwasa.  
Close